Technical Coordination Lead - 3D Modeling
About the job
- A degree in Civil Engineering, Structural Engineering, Mechanical Engineering, or a related field.
- Dedicated experience in BIM and 3D model coordination.
- Experience in engineering coordination, technical leadership, or project management; experience in API or biotechnology is preferred.
- BIM/3D modeling certification.
- Knowledge of Good Manufacturing Practice (GMP) and pharmaceutical engineering.
- Ability to lead inter-discipline review meetings and resolve technical conflicts among multiple stakeholders.
- Experience interfacing with HSE, Quality, Operations, and Maintenance teams on technical matters.
- Fluency in English is required.
- Define and enforce 3D modeling governance, including naming conventions, Level of Development (LOD) requirements, and modeling protocols across engineering disciplines.
- Serve as the primary BIM contact for the PMC BIM team (T.EN), acting as the key interface between Sanofi and the Engineering Contractor's BIM Manager to ensure model quality and data integrity.
- Organize and lead regular clash detection sessions and inter-discipline review meetings between Engineering teams, Maintenance, and Operations; identify and resolve technical interfaces and conflicts between disciplines, Quality, HSE, and Operations and Maintenance.
- Schedule and facilitate formal 3D model review milestones at 30%, 60%, and 90% IFC with all disciplines, including HSE, Operations, and Maintenance.
- Ensure full discipline model federation, verifying that piping, structure, equipment, HVAC, and electrical tray models are integrated, up to date, and ready for presentation to HSE, Operations, and Maintenance teams.
- Manage and track 3D model-related issues, maintain the interface register, and monitor resolution of open technical coordination points raised by Sanofi.
- Oversee As-Built model alignment, ensuring the 3D model is continuously updated to reflect construction changes and serves as the basis for as-built documentation.
- Act as the primary technical point of contact for HSE, Quality, Maintenance, and Operations stakeholders regarding BIM requests, questions, and technical coordination matters.
- Review and approve key technical deliverables and engineering documents; participate in technical deviation management and change requests to ensure alignment across Sanofi engineering disciplines, including civil, structural, mechanical, piping, electrical, instrumentation, and HVAC, with Maintenance and Operations.
- Additional languages are welcome.
About the company
Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.
Company Size
10,001+
Company Stage
IPO
Headquarters
Paris, France
Founded
1973
Get referred to Sanofi
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
- June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
- Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.
What critics are saying
- Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
- Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
- Dupixent concentration makes 2030s patent loss an existential revenue shock.
What makes Sanofi unique
- Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
- October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
- Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Professional Development Budget
- Parental Leave